Besir Besir, Ali Majeed-Saidan Maryam Muhammad, Ramu Shivabalan Kathavarayan, Lomaia Tamari, Rajendran Judah, Iskandar Odette, Motairek Issam, Harb Serge C, Miyasaka Rhonda, Yun James, Puri Rishi, Reed Grant W, Krishnaswamy Amar, Kapadia Samir R
Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA.
Struct Heart. 2025 May 12;9(10):100645. doi: 10.1016/j.shj.2025.100645. eCollection 2025 Oct.
Flow is known to typically improve after transcatheter aortic valve replacement (TAVR); however, the characteristics correlating with improvement are still unclear. This study sought to explore the outcomes of patients with low-flow low-gradient aortic stenosis (LFLG AS) and flow improvement following TAVR compared to those without flow improvement, in addition to the predictors of flow improvement.
This is a retrospective cohort of patients >18 years of age who underwent TAVR at Cleveland Clinic between 2016 and 2020. Only patients with aortic valve area <1 cm, aortic valve mean gradient <40 mmHg, and stroke volume index (SVI) <35 mL/m were included. Patients were classified into 2 groups according to whether SVI improved by 20% or more at the 30-day follow-up. Patients who underwent valve-in-valve TAVR were excluded. Binary logistic regression was used to evaluate the predictors of flow improvement.
A total of 633 patients had LFLG AS. Two hundred twenty-eight patients (36%) had SVI improvement by 20% or more. Male sex, left ventricular ejection fraction (LVEF) improvement by 10% or more 30 days post-TAVR, lower baseline SVI and paradoxical LFLG AS predicted flow improvement. There was no difference in mortality and heart failure rehospitalization between patients with and without flow improvement.
One-third of patients with LFLG AS show an improvement in flow post-TAVR. Paradoxical LFLG AS, male sex, lower baseline SVI, and improvement in LVEF correlated with flow improvement, whereas baseline LVEF did not. There was no difference in clinical outcomes between patients with and without flow improvement post-TAVR.
经导管主动脉瓣置换术(TAVR)后血流通常会改善;然而,与改善相关的特征仍不明确。本研究旨在探讨低流量低梯度主动脉瓣狭窄(LFLG AS)患者TAVR后血流改善与未改善患者的结局,以及血流改善的预测因素。
这是一项对2016年至2020年在克利夫兰诊所接受TAVR的18岁以上患者的回顾性队列研究。仅纳入主动脉瓣面积<1 cm、主动脉瓣平均压差<40 mmHg且每平方米体表面积的每搏输出量(SVI)<35 mL的患者。根据30天随访时SVI是否改善20%或更多将患者分为两组。接受瓣中瓣TAVR的患者被排除。采用二元逻辑回归评估血流改善的预测因素。
共有633例患者患有LFLG AS。228例患者(36%)的SVI改善20%或更多。男性、TAVR术后30天左心室射血分数(LVEF)改善10%或更多、较低的基线SVI以及矛盾性LFLG AS可预测血流改善。血流改善与未改善的患者在死亡率和心力衰竭再住院方面无差异。
三分之一的LFLG AS患者TAVR后血流有所改善。矛盾性LFLG AS、男性、较低的基线SVI以及LVEF改善与血流改善相关,而基线LVEF则不然。TAVR后血流改善与未改善的患者临床结局无差异。